Transcriptomic Profiling Identifies Differentially Expressed Genes in Palbociclib-Resistant ER+ MCF7 Breast Cancer Cells
Open Access
- 23 April 2020
- Vol. 11 (4), 467
- https://doi.org/10.3390/genes11040467
Abstract
Acquired resistance to cyclin-dependent kinases 4 and 6 (CDK4/6) inhibition in estrogen receptor-positive (ER+) breast cancer remains a significant clinical challenge. Efforts to uncover the mechanisms underlying resistance are needed to establish clinically actionable targets effective against resistant tumors. In this study, we sought to identify differentially expressed genes (DEGs) associated with acquired resistance to palbociclib in ER+ breast cancer. We performed next-generation transcriptomic RNA sequencing (RNA-seq) and pathway analysis in ER+ MCF7 palbociclib-sensitive (MCF7/pS) and MCF7 palbociclib-resistant (MCF7/pR) cells. We identified 2183 up-regulated and 1548 down-regulated transcripts in MCF7/pR compared to MCF7/pS cells. Functional analysis of the DEGs using Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) database identified several pathways associated with breast cancer, including ‘cell cycle’, ‘DNA replication’, ‘DNA repair’ and ‘autophagy’. Additionally, Ingenuity Pathway Analysis (IPA) revealed that resistance to palbociclib is closely associated with deregulation of several key canonical and metabolic pathways. Further studies are needed to determine the utility of these DEGs and pathways as therapeutics targets against ER+ palbociclib-resistant breast cancer.Keywords
This publication has 58 references indexed in Scilit:
- Polo-like kinase 1 (Plk1): an Unexpected Player in DNA ReplicationCell Division, 2012
- PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitroBreast Cancer Research, 2009
- Identification of cisplatin‐resistance related genes in head and neck squamous cell carcinomaInternational Journal of Cancer, 2009
- BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor ActivityClinical Cancer Research, 2009
- Membrane proteomics of phagosomes suggests a connection to autophagyProceedings of the National Academy of Sciences, 2008
- αB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancerBreast Cancer Research and Treatment, 2007
- αB-Crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancerJCI Insight, 2005
- αB‐crystallin as a marker of lymph node involvement in breast carcinomaCancer, 2004
- Polo-like kinases and the orchestration of cell divisionNature Reviews Molecular Cell Biology, 2004
- LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processingThe EMBO Journal, 2000